Table 2

Validation of Syndromic Surveillance for Respiratory Pathogen Activity

Cees van den Wijngaard*

, Liselotte van Asten*, Wilfrid van Pelt*, Nico J.D. Nagelkerke†, Robert Verheij‡, Albert J. de Neeling*, Arnold Dekkers*, Marianne A.B. van der Sande*, Hans van Vliet*, and Marion P.G. Koopmans*

Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands; †United Arab Emirates University, Al-Ain, United Arab Emirates; ‡Netherlands Institute of Health Services Research, Utrecht, the Netherlands;

Main Article

Pearson correlation coefficients between time series of syndromes and laboratory pathogen counts, the Netherlands, 1999–2004*†

Pathogen	Hospital	GP	Mortality	Pharmacy	Laboratory submissions	Absenteeism
RSV	0.74	0.67	0.41	0.58	0.53	0.47
Influenza A	0.57	0.61	0.65	0.60	0.47	0.35
Influenza B	0.31	0.39	0.50	0.42	0.34	0.33
Streptococcus pneumoniae	0.73	0.71	0.56	0.75	0.58	0.69
Rhinovirus	0.33	0.34	0.33	0.33	NS	0.35
Parainfluenza	0.20	NS	NS	NS	0.25	NS
Adenovirus	0.37	0.35	0.33	0.36	NS	0.34
Enterovirus	−0.65	−0.66	−0.59	−0.61	−0.57	−0.51
Mycoplasma pneumoniae	0.13	0.27	0.25	0.39	0.32	0.26
Bordetella pertussis	NS	NS	NS	NS	NS	NS

*GP, general practice; RSV, respiratory syncytial virus; NS, nonsignificant. Correlations >0.50 in boldface; p>0.05.
†Unlagged.

Main Article

Page created: July 09, 2010

Page updated: July 09, 2010

Page reviewed: July 09, 2010

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.